Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesLymph NodesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTreatment OutcomeGraft SurvivalTissue DonorsBusulfanCombined Modality TherapyBone Marrow PurgingCyclophosphamideHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityLymphRecurrenceTransplantation, IsogeneicBone Marrow DiseasesRetrospective StudiesKidney TransplantationTime FactorsHematopoiesisImmunosuppressive AgentsMice, Inbred C57BLRadiation ChimeraFatal OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisBone Marrow ExaminationLeukemia, Myeloid, AcutePrognosisAcute DiseaseRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingFollow-Up StudiesBone Marrow NeoplasmsTransplantation ImmunologySurvival RateGraft vs Host ReactionLeukemia, MyeloidAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressionLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationT-LymphocytesDisease-Free SurvivalSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisCyclosporineHodgkin DiseaseBone DensityHematologic DiseasesLymphocyte TransfusionNuclear FamilySpleenCarmustineCell DifferentiationOrgan TransplantationProspective StudiesPancytopeniaGraft vs Tumor EffectMethotrexateLeukocyte CountMice, Inbred BALB CGraft vs Leukemia EffectCytarabineCytomegalovirus InfectionsBone ResorptionGranulocyte Colony-Stimulating FactorFlow CytometryMelphalanRisk FactorsPostoperative ComplicationsLymphomaEtoposideMultiple MyelomaCells, Cultured